Strongbridge Biopharma plc·4

May 16, 4:14 PM ET

Steineger Hilde H 4

4 · Strongbridge Biopharma plc · Filed May 16, 2019

Insider Transaction Report

Form 4
Period: 2019-05-15
Transactions
  • Award

    Ordinary Shares

    2019-05-15+40,00040,000 total
Footnotes (1)
  • [F1]Represents a grant of restricted stock units, which vest in full on May 15, 2020, provided that the Reporting Person continues to provide service as a member of the Board continuously from the Grant Date through such one-year anniversary. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -